On October 30, HRSA announced that it had selected eight drug manufacturers to participate in its 340B Rebate Model Pilot Program, spanning 10 drugs representing a range of widely used therapies.

“When a program designed to deliver targeted assistance drives up system-wide costs, reform is no longer optional,” says health expert Sally Pipes. “It's necessary.” If a charity organization ...

Phoebe Putney Health System today announced the launch of the Rural Health Report, a new public information series ...

Forbes contributors publish independent expert analyses and insights. I am a cable news contributor and professor of journalism. This voice experience is generated by AI. Learn more. This voice ...

Four drug manufacturers have announced plans to offer discounted drug prices to safety net providers under the federal 340B program via rebates instead of upfront discounts, despite the federal ...

340B IN THE HOT SEAT, AGAIN — Sen. Bill Cassidy (R-La.) is making a push to overhaul the 340B drug discount program, which has been the focal point of a lobbying war between hospitals and drugmakers ...

The CMS proposed a rule on Thursday that would slash Medicare payment rates for a program that hospitals use to buy discounted drugs and implement site-neutral payments for some imaging services next ...

The 340B program allows certain nonprofit hospitals to buy prescription drugs at a significant discount. Larger urban hospitals generate most of the 340B revenue, while smaller rural clinics struggle ...

Duplicate Discounts And The Proposed 340B Rebate Model The 340B Drug Pricing Program is a federal program in which participating hospitals and clinics are able to purchase qualifying drugs from ...

Outpatient drug purchases under the 340B Drug Pricing Program crossed the $100 billion mark across 2025, a roughly 23% increase over the $81.4 billion of 2024, the Health Resources & Services ...